14.04.2011 - Roche is poised to kick off the Big Pharma reporting season with a drop in sales due to weaker demand for top-selling Avastin and flu drug Tamiflu and governments' drive to cut...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)